Cisen Pharmaceutical Co., Ltd. (603367.SS)

CNY 14.05

(0.0%)

Total Debt Summary of Cisen Pharmaceutical Co., Ltd.

  • Cisen Pharmaceutical Co., Ltd.'s latest annual total debt in 2023 was 170.67 Million CNY , up 7.61% from previous year.
  • Cisen Pharmaceutical Co., Ltd.'s latest quarterly total debt in 2024 Q3 was 74.06 Million CNY , down -77.54% from previous quarter.
  • Cisen Pharmaceutical Co., Ltd. reported annual total debt of 158.6 Million CNY in 2022, up 10.42% from previous year.
  • Cisen Pharmaceutical Co., Ltd. reported annual total debt of 143.63 Million CNY in 2021, down -56.47% from previous year.
  • Cisen Pharmaceutical Co., Ltd. reported quarterly total debt of 74.06 Million CNY for 2024 Q3, down -77.54% from previous quarter.
  • Cisen Pharmaceutical Co., Ltd. reported quarterly total debt of 203.02 Million CNY for 2024 Q1, up 18.95% from previous quarter.

Annual Total Debt Chart of Cisen Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Total Debt of Cisen Pharmaceutical Co., Ltd. (2023 - 2011)

Year Total Debt Total Debt Growth
2023 170.67 Million CNY 7.61%
2022 158.6 Million CNY 10.42%
2021 143.63 Million CNY -56.47%
2020 330 Million CNY 230.0%
2019 100 Million CNY -22.63%
2018 129.25 Million CNY -16.07%
2017 154 Million CNY -38.4%
2016 250 Million CNY 66.67%
2015 150 Million CNY 0.0%
2014 150 Million CNY 50.0%
2013 100 Million CNY 0.0%
2012 100 Million CNY 0.0%
2011 - CNY 0.0%

Peer Total Debt Comparison of Cisen Pharmaceutical Co., Ltd.

Name Total Debt Total Debt Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 1.58 Billion CNY 89.218%
Yabao Pharmaceutical Group Co., Ltd 209 Million CNY 18.338%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 15.79 Billion CNY 98.919%
Harbin Pharmaceutical Group Co., Ltd. 3.55 Billion CNY 95.204%
Tasly Pharmaceutical Group Co., Ltd 2.95 Billion CNY 94.233%
Zhejiang Medicine Co., Ltd. 801.44 Million CNY 78.704%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 839.84 Million CNY 79.678%
Lionco Pharmaceutical Group Co.,Ltd. 565.61 Million CNY 69.825%
Humanwell Healthcare (Group) Co.,Ltd. 9.94 Billion CNY 98.284%
Ginwa Enterprise (Group) Inc. 10.77 Million CNY -1483.826%
Joincare Pharmaceutical Group Industry Co.,Ltd. 7.4 Billion CNY 97.694%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 175.68 Million CNY 2.854%
China Animal Husbandry Industry Co., Ltd. 1.45 Billion CNY 88.279%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 9.91 Million CNY -1622.227%
Zhejiang Huahai Pharmaceutical Co., Ltd. 7.45 Billion CNY 97.71%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.08 Billion CNY 84.234%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.3 Billion CNY 86.896%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 727.9 Million CNY 76.553%
Chongqing Taiji Industry(Group) Co.,Ltd 4.86 Billion CNY 96.489%
HPGC Renmintongtai Pharmaceutical Corporation 2.33 Billion CNY 92.685%
Nanjing Well Pharmaceutical Group Co.,Ltd. 486.95 Million CNY 64.951%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 995.24 Million CNY 82.851%
Henan Lingrui Pharmaceutical Co., Ltd. 149.26 Million CNY -14.342%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.2 Billion CNY 85.822%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.07 Billion CNY 84.184%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 48.13 Million CNY -254.574%
Zhongzhu Healthcare Holding Co.,Ltd 23.94 Million CNY -612.869%
Beijing Tongrentang Co., Ltd 3.42 Billion CNY 95.019%
KPC Pharmaceuticals, Inc. 1.17 Billion CNY 85.428%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 17.28 Million CNY -887.598%
North China Pharmaceutical Company Ltd. 11.72 Billion CNY 98.545%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 462.87 Million CNY 63.128%
Tibet Weixinkang Medicine Co., Ltd. 7.68 Million CNY -2121.702%
China National Medicines Corporation Ltd. 3.15 Billion CNY 94.595%
Zhejiang Hisun Pharmaceutical Co., Ltd. 5.69 Billion CNY 97.002%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.15 Billion CNY 94.583%
ChengDu ShengNuo Biotec Co.,Ltd. 267.22 Million CNY 36.13%
Dali Pharmaceuticalco.,Ltd 23.66 Million CNY -621.285%
Changchun BCHT Biotechnology Co. 20.47 Million CNY -733.695%
Zhejiang Shengda Bio-Pharm Co., Ltd. 238.44 Million CNY 28.421%
Shanghai Jiaoda Onlly Co.,Ltd 208.92 Million CNY 18.31%
Jiang Zhong Pharmaceutical Co.,Ltd 56.62 Million CNY -201.418%
Mayinglong Pharmaceutical Group Co., LTD. 380.42 Million CNY 55.136%
Hunan Warrant Pharmaceutical Co.,Ltd 24.18 Million CNY -605.805%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 35.72 Billion CNY 99.522%
Jianmin Pharmaceutical Group Co.,Ltd. 501.17 Million CNY 65.945%
Hunan Fangsheng Pharmaceutical Co., Ltd. 679.7 Million CNY 74.89%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.78 Billion CNY 90.441%
Guobang Pharma Ltd. 963.26 Million CNY 82.282%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 659.05 Million CNY 74.103%
Kangmei Pharmaceutical Co., Ltd. 255.01 Million CNY 33.072%
Shandong Buchang Pharmaceuticals Co., Ltd. 3.4 Billion CNY 94.993%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.19 Billion CNY 94.652%
Henan Taloph Pharmaceutical Stock Co.,Ltd 819.3 Million CNY 79.168%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 116.7 Million CNY -46.243%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 2.62 Billion CNY 93.5%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 446.65 Million CNY 61.788%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.75 Billion CNY 90.248%
Shanghai Yizhong Pharmaceutical Co., Ltd. 44.02 Million CNY -287.649%
Tibet Rhodiola Pharmaceutical Holding Co. 501.52 Million CNY 65.969%
Sichuan Huiyu Pharmaceutical Co., Ltd. 435.5 Million CNY 60.81%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 443.84 Million CNY 61.546%
CanSino Biologics Inc. 2.71 Billion CNY 93.713%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 705.78 Million CNY 75.818%
Shandong Lukang Pharmaceutical Co.,Ltd. 3.43 Billion CNY 95.032%